Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China · Delayed Price · Currency is CNY 4.800
-0.100 (-2.04%)
At close: Feb 13, 2026
SHA:603718 Market Cap
SHA:603718 has a market cap or net worth of 3.13 billion as of February 13, 2026. Its market cap has decreased by -27.94% in one year.
Market Cap
3.13B
Enterprise Value
2.84B
Revenue
246.35M
Ranking
n/a
PE Ratio
18.09
Stock Price
4.80
Market Cap Chart
Since May 15, 2015, SHA:603718's market cap has increased from 2.75B to 3.13B, an increase of 13.92%. That is a compound annual growth rate of 1.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.13B | -21.76% |
| Dec 31, 2025 | 4.00B | -12.02% |
| Dec 31, 2024 | 4.55B | -35.48% |
| Dec 29, 2023 | 7.05B | 11.42% |
| Dec 30, 2022 | 6.32B | -35.82% |
| Dec 31, 2021 | 9.85B | 21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yantai Zhenghai Biotechnology | 3.65B |
| Beijing Kawin Technology Share-Holding | 3.65B |
| Shanghai Model Organisms Center | 3.48B |
| Guangdong VTR Bio-Tech | 3.27B |
| Cabio Biotech (Wuhan) | 3.24B |
| Suzhou Fushilai Pharmaceutical | 3.11B |
| Novoprotein Scientific | 3.02B |
| Shanghai Universal Biotech | 2.88B |